Valerio Liguori - Publications

Ocular disorders during treatment with GLP-1 receptor agonists: a systematic review and meta-analysis of observational studies.

Journal: Frontiers in pharmacology

Published: February 10, 2026

Safety profile of FLT3 inhibitors in acute myeloid leukemia: a systematic review and meta-analysis of adverse events.

Journal: Clinical and experimental medicine

Published: November 21, 2025

Evaluation of the safety profile of glucagon-like peptide-1 receptor agonists: a focus on thyroid cancer-related adverse events by using the European pharmacovigilance database.

Journal: Pharmacological reports : PR

Published: July 03, 2025

Uncovering prognostic biomarkers through a pharmacovigilance study: the case of RDW.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 13, 2025

The Use of Botulinum Toxin Type A and the Occurrence of Anaphylaxis: A Descriptive Analysis of Data from the European Spontaneous Reporting System.

Journal: Aesthetic plastic surgery

Published: September 02, 2024

Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series.

Journal: Frontiers in neurology

Published: February 15, 2024

Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system.

Journal: Frontiers in neurology

Published: February 08, 2024

Skin Toxicities Associated with Botulin Toxin Injection for Aesthetic Procedures: Data from the European Spontaneous Reporting System.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 25, 2023

The Safety Profiles of Two First-Generation NTRK Inhibitors: Analysis of Individual Case Safety Reports from the FDA Adverse Event Reporting System (FAERS) Database.

Journal: Biomedicines

Published: August 28, 2023

Multisystem Inflammatory Syndrome in Children Following COVID-19 Vaccination: A Sex-Stratified Analysis of the VAERS Database Using Brighton Collaboration Criteria.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 20, 2023

A Pharmacovigilance Study on the Safety of Axicabtagene Ciloleucel Based on Spontaneous Reports from the EudraVigilance Database.

Journal: Biomedicines

Published: July 06, 2023

Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 04, 2023